EU antitrust authorities launch official probe of Teva over Copaxone drug

European Union antitrust authorities will formally probe Israeli drugmaker Teva, Reuters reports, over suspicions it took illegal steps to thwart rivals on its Copaxone drug, used to treat multiple sclerosis.

A preliminary probe was opened late last year, leading to the latest decision.